BDMAX
Price
$13.93
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
BDMCX
Price
$12.84
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
Ad is loading...

BDMAX vs BDMCX

Header iconBDMAX vs BDMCX Comparison
Open Charts BDMAX vs BDMCXBanner chart's image
BlackRock Global Equity Mkt Netrl A
Price$13.93
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
BlackRock Global Equity Mkt Netrl C
Price$12.84
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BDMAX vs BDMCX Comparison Chart
Loading...
VS
BDMAX vs. BDMCX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDMAX is a Hold and BDMCX is a Hold.

FUNDAMENTALS
Fundamentals
BDMAX (2.55B) and BDMCX (2.55B) have equal amount of cash in the bank . BDMAX (6.53) and BDMCX (6.49) have matching dividends . BDMAX was incepted earlier than BDMCX: BDMAX (12 years) vs BDMCX (12 years). BDMAX (79.00) and BDMCX (79.00) have comparable annual turnover. BDMAX (1000) and BDMCX (1000) have matching initial minimum investment requirements. BDMAX (25.82) and BDMCX (24.81) have marching annual gain over last year. BDMAX return over 5 years is better than : 32.76 vs. BDMCX (27.96).
BDMAXBDMCXBDMAX / BDMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years12 years-
Gain YTD20.51719.681104%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.55B2.55B100%
Annual Yield % from dividends6.536.49101%
Returns for 1 year25.8224.81104%
Returns for 3 years39.9936.83109%
Returns for 5 years32.7627.96117%
Returns for 10 years36.2627.41132%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICCC3.590.01
+0.28%
ImmuCell Corp
IQ2.46N/A
N/A
iQIYI
CARS15.88-0.15
-0.94%
Cars.com
ON69.50-1.49
-2.10%
ON Semiconductor Corp
ABEO6.04-0.21
-3.36%
Abeona Therapeutics